Setting Realistic Expectations Successful lipedema management often involves reframing your relationship with weight loss and body changes
Overall prescribing trends The study found that 2,855,602 patients were prescribed a GLP-1 RA between January 2019 and March 2026, with 14,738,765 total prescriptions during this period
performed a phase 2 trial, to investigate the impact of tirzepatide, on biomarkers related to NASH and liver fibrosis in individuals with Type 2 Diabetes (T2D)
If you are thinking about a tan jab, this article lays out what Melanotan II is, what can go wrong, and what safer options look like day to day
The GIP receptor agonism component is what distinguishes tirzepatide from single-agonist GLP-1 medications